血液分析仪及试剂市场－全球产业规模、份额、趋势、机会及预测：产品及服务、终端用户、应用、地区及竞争格局（2021-2031年）

全球血液分析仪和试剂市场预计将从 2025 年的 23.2 亿美元成长到 2031 年的 35.1 亿美元，复合年增长率为 7.14%。

血液分析仪作为自动化系统，可进行血球计数和形态学分析，而试剂则是实现这些诊断程序的关键化学溶液。推动该市场发展的主要因素是全球血液疾病（如白血病和贫血）盛行率的不断上升，这导致对高通量、高精度检测的持续需求。临床检查室为提高营运效率而大力推动高通量自动化，进一步加剧了这项需求。美国癌症协会估计，到2025年，美国将新增66,890例白血病病例，凸显了诊断能力的迫切性。

儘管市场呈现上升趋势，但由于购买和维护先进的血液学检测系统需要高昂的资本成本，因此仍面临许多障碍。这项资金需求限制了技术的普及率，尤其是在预算有限的新兴市场小规模独立实验室和医疗机构。此外，各地区复杂多元的法规环境也可能延缓创新诊断技术的核准和市场准入，减缓整个产业的扩张速度。

市场驱动因素

人工智慧 (AI) 与数位影像技术的整合正在改变市场格局，显着提升诊断准确性并优化检查室工作流程。借助 AI 驱动的演算法，检查室可以实现血球形态学检测的自动化，减少对人工显微镜的依赖，降低人为误差的风险。这项技术进步能够加快检测结果的交付速度，并提高检测结果的一致性，使其成为高通量检测中心不可或缺的一部分。 2025 年 7 月，Scopio Labs 的 AI 应用程式获得 FDA 批准，该应用能够分析红血球形态和血小板凝集聚集情况，从而优化数位血液学检测流程，这标誌着该领域取得了一项重大进展。

同时，随着临床检查室寻求整合检测流程，自动化和整合化血液学检测工作站的日益普及正在推动市场成长。在人力有限的情况下，将细胞计数、玻片製备和染色整合于单一平台的高通量分析仪对于处理日益增长的检体量至关重要。这种向自动化的转变也反映在主要企业的财务表现中。例如，迈瑞医疗在2025年4月报告称，由于市场对自动化解决方案的强劲需求，其体外诊断业务在2024年的销售额增长了约11%。此外，英国国家医疗服务体系（NHS England）2025年8月的数据显示，与前一年相比，2024年7月至2025年6月期间新增了超过160万次诊断测试和扫描，这凸显了高效基础设施的迫切需求。

市场挑战

安装和维护先进的血液分析仪需要大量的资本投入，这构成了市场发展的一大阻碍因素。这些诊断系统需要大量的预付费用，这往往成为预算有限的小规模独立实验室和医疗机构采用这些系统的障碍。除了初始购置成本外，专用试剂、服务合约、操作人员培训等持续累积的成本也会进一步加剧财务压力。因此，许多机构被迫延长旧设备的使用寿命，而不是升级到更新、更有效率的自动化系统，减缓了维持市场成长所需的更新速度。

这种经济压力直接阻碍了下一代诊断技术的应用。据美国医院协会 (AHA) 称，到 2025 年，94% 的医疗机构管理者预计将因财务挑战而推迟设备升级。这种不愿投资资本资产的做法限制了新系统的部署数量，并抑制了製造商的收入成长。因此，由于采购决策经常被推迟以节省营运资金，市场在采用先进血液学解决方案方面正经历放缓。

市场趋势

照护现场（POC​​）血液检测的日益普及正在重塑市场格局，它分散了诊断能力，并加快了重症监护环境下的检测结果出炉速度。医疗机构正越来越多地部署采用微流体技术的紧凑型便携式分析仪，使他们能够在患者床边直接进行检查室级的血液常规检查（CBC）检测，从而消除了与中心检查室相关的物流延误。这种转变在急诊室尤其重要，因为快速的临床决策至关重要。例如，PixCell Medical公司于2025年6月发表的一项题为「利用HemoScreen CBC检测改变智利急诊护理」的案例研究表明，该公司的照护现场检测分析仪可在10分钟内提供检测结果，平均比传统检查室检测快20分钟。

同时，新的临床参数和生物标记的引入推动了对先进试剂和灵敏分析的需求。检查室不再局限于标准的细胞计数，而是采用诸如未成熟血小板比例和网状红血球血红蛋白等高级指标，从而更深入地了解脓毒症和贫血等病理状况。这种对精细细胞分析的关注需要使用专业化的、高附加价值的专有试剂，从而直接提升了製造商的收入。希森美康公司（Sysmex Corporation）于2025年5月发布的《截至2025年3月的财年概要》也强调了这一趋势，该报告显示，亚太地区血液学检测部门的销售额同比增长17.6%。这一增长主要归功于对诊断设备和试剂需求的不断增长。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球血液分析仪及试剂市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依产品/服务分类（血液学、止血学、免疫血液学、血浆蛋白分析仪、血红素分析仪、红血球沉积速率分析仪、凝血分析仪、流式细胞仪、白血球分化分析仪）
  • 依最终使用者（医院检查室、血库、研究/学术机构、其他）划分
  • 依应用领域（贫血、血癌、出血性疾病、感染疾病、免疫系统相关疾病等）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章 北美血液分析仪与试剂市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲血液分析仪与试剂市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区血液分析仪及试剂市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东及非洲血液分析仪及试剂市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美血液分析仪与试剂市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球血液分析仪及试剂市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Sysmex Corporation
• Danaher Corporation
• Nihon Kohden Corporation
• Siemens Healthineers AG
• Abbott Laboratories
• Boule Diagnostics AB
• Bio-Rad Laboratories Inc.
• Biosystems SA
• EKF Diagnostics Holdings Plc
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Hematology Analyzers and Reagents Market is projected to expand from USD 2.32 Billion in 2025 to USD 3.51 Billion by 2031, registering a CAGR of 7.14%. Hematology analyzers act as automated systems for blood cell counting and morphology analysis, while reagents serve as the vital chemical solutions that enable these diagnostic procedures. The primary factor driving this market is the growing global prevalence of blood disorders, such as leukemia and anemia, which creates a sustained demand for high-volume, accurate testing. This need is further amplified by the push for high-throughput automation within clinical laboratories to enhance operational efficiency. Highlighting this urgency, the American Cancer Society estimates that 66,890 new cases of leukemia will be diagnosed in the United States in 2025, necessitating robust diagnostic capabilities.

Despite this upward trajectory, the market encounters a substantial hurdle due to the high capital costs associated with purchasing and maintaining advanced hematology systems. This financial requirement restricts adoption rates, particularly among smaller independent laboratories and healthcare facilities in emerging markets that operate with limited budgets. Furthermore, complex and divergent regulatory environments across different regions can postpone the approval and market entry of innovative diagnostic technologies, thereby slowing the overall pace of industry expansion.

Market Driver

The incorporation of artificial intelligence and digital imaging technologies is transforming the market by significantly improving diagnostic accuracy and laboratory workflow. By utilizing AI-driven algorithms, laboratories can automate the morphological examination of blood cells, reducing the dependency on manual microscopy and mitigating the risk of human error. This technological evolution enables faster turnaround times and more consistent outcomes, which is essential for high-volume testing centers. A notable development in this sector was reported by Scopio Labs in July 2025, when the company obtained FDA clearance for an AI-powered application capable of analyzing red blood cell morphology and platelet clumps, thereby optimizing digital hematology processes.

Simultaneously, the rising adoption of automated and integrated hematology workstations is fueling market growth as clinical laboratories aim to consolidate their testing operations. High-throughput analyzers that integrate cell counting, slide preparation, and staining into a single platform are becoming indispensable for managing growing sample volumes amidst staffing constraints. This shift toward automation is reflected in the financial results of key industry players; for instance, Mindray reported in April 2025 that its In-Vitro Diagnostics revenue increased by nearly 11% in 2024, leading its divisions due to robust demand for automated solutions. Additionally, NHS England data from August 2025 indicated that over 1.6 million extra diagnostic tests and scans were conducted between July 2024 and June 2025 compared to the prior year, underscoring the vital need for efficient infrastructure.

Market Challenge

The substantial capital investment necessary to acquire and maintain sophisticated hematology analyzers acts as a major restraint on the market. These diagnostic systems require significant upfront expenditure, which is often prohibitive for smaller independent laboratories and healthcare facilities operating with constrained budgets. Beyond the initial purchase price, the ongoing cumulative costs of proprietary reagents, service agreements, and operator training place further stress on financial resources. Consequently, many institutions are compelled to extend the lifespan of older equipment rather than upgrading to newer, more efficient automation, thereby slowing the replacement rate required for market momentum.

This economic pressure directly hampers the adoption of next-generation diagnostic technologies. According to the American Hospital Association, in 2025, 94% of healthcare administrators anticipated delaying equipment upgrades to manage financial challenges. Such reluctance to invest in capital assets limits the number of new system installations and restricts revenue growth for manufacturers. As a result, the market experiences a slowdown in the proliferation of advanced hematology solutions, as purchasing decisions are frequently deferred to conserve operational capital.

Market Trends

The growing utilization of point-of-care (POC) hematology testing is reshaping the market by decentralizing diagnostic capabilities and accelerating results in critical care settings. Healthcare facilities are increasingly adopting compact, portable analyzers that employ microfluidic technology to perform lab-quality complete blood counts directly at the patient's bedside, thereby eliminating the logistical delays associated with central laboratories. This transition is particularly significant in emergency departments where rapid clinical decisions are crucial; for example, a case study by PixCell Medical in June 2025, titled 'Transforming Emergency Care in Chile with HemoScreen CBC Testing,' demonstrated that their point-of-care analyzer provided results in under 10 minutes, averaging 20 minutes faster than traditional laboratory testing.

In parallel, the introduction of novel clinical parameters and biomarkers is driving demand for advanced reagents and high-sensitivity analysis. Laboratories are moving beyond standard cell counts to incorporate advanced metrics such as immature platelet fraction and reticulocyte hemoglobin, which offer deeper insights into conditions like sepsis and anemia. This focus on detailed cellular profiling requires the consumption of specialized, high-value proprietary reagents, directly boosting manufacturer revenues. This trend is evident in Sysmex Corporation's May 2025 report, 'Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2025,' which noted a 17.6% year-on-year increase in hematology segment sales within the Asia Pacific region, attributed largely to the rising demand for diagnostic instruments and reagents.

Key Market Players

• Sysmex Corporation
• Danaher Corporation
• Nihon Kohden Corporation
• Siemens Healthineers AG
• Abbott Laboratories
• Boule Diagnostics AB
• Bio-Rad Laboratories Inc.
• Biosystems S.A.
• EKF Diagnostics Holdings Plc
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Report Scope

In this report, the Global Hematology Analyzers and Reagents Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Hematology Analyzers and Reagents Market, By Product And Services

• Hematology
• Hemostasis
• Immunohematology
• Plasma Protein Analyzer
• Hemoglobin Analyzers
• Erythrocyte Sedimentation Rate Analyzer
• Coagulation Analyzer
• Flow Cytometers
• Differential Counters

Hematology Analyzers and Reagents Market, By End User

• Hospital Laboratories
• Blood Banks
• Research and Academic Institute
• Others

Hematology Analyzers and Reagents Market, By Application

• Anemia
• Blood Cancer
• Hemorrhagic Conditions
• Infection-Related Conditions
• Immune-System Related Conditions
• Others

Hematology Analyzers and Reagents Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Hematology Analyzers and Reagents Market.

Available Customizations:

Global Hematology Analyzers and Reagents Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Hematology Analyzers and Reagents Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product And Services (Hematology, Hemostasis, Immunohematology, Plasma Protein Analyzer, Hemoglobin Analyzers, Erythrocyte Sedimentation Rate Analyzer, Coagulation Analyzer, Flow Cytometers, Differential Counters)
  • 5.2.2. By End User (Hospital Laboratories, Blood Banks, Research and Academic Institute, Others)
  • 5.2.3. By Application (Anemia, Blood Cancer, Hemorrhagic Conditions, Infection-Related Conditions, Immune-System Related Conditions, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Hematology Analyzers and Reagents Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product And Services
  • 6.2.2. By End User
  • 6.2.3. By Application
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Hematology Analyzers and Reagents Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product And Services
      • 6.3.1.2.2. By End User
      • 6.3.1.2.3. By Application
  • 6.3.2. Canada Hematology Analyzers and Reagents Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product And Services
      • 6.3.2.2.2. By End User
      • 6.3.2.2.3. By Application
  • 6.3.3. Mexico Hematology Analyzers and Reagents Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product And Services
      • 6.3.3.2.2. By End User
      • 6.3.3.2.3. By Application

7. Europe Hematology Analyzers and Reagents Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product And Services
  • 7.2.2. By End User
  • 7.2.3. By Application
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Hematology Analyzers and Reagents Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product And Services
      • 7.3.1.2.2. By End User
      • 7.3.1.2.3. By Application
  • 7.3.2. France Hematology Analyzers and Reagents Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product And Services
      • 7.3.2.2.2. By End User
      • 7.3.2.2.3. By Application
  • 7.3.3. United Kingdom Hematology Analyzers and Reagents Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product And Services
      • 7.3.3.2.2. By End User
      • 7.3.3.2.3. By Application
  • 7.3.4. Italy Hematology Analyzers and Reagents Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product And Services
      • 7.3.4.2.2. By End User
      • 7.3.4.2.3. By Application
  • 7.3.5. Spain Hematology Analyzers and Reagents Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product And Services
      • 7.3.5.2.2. By End User
      • 7.3.5.2.3. By Application

8. Asia Pacific Hematology Analyzers and Reagents Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product And Services
  • 8.2.2. By End User
  • 8.2.3. By Application
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Hematology Analyzers and Reagents Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product And Services
      • 8.3.1.2.2. By End User
      • 8.3.1.2.3. By Application
  • 8.3.2. India Hematology Analyzers and Reagents Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product And Services
      • 8.3.2.2.2. By End User
      • 8.3.2.2.3. By Application
  • 8.3.3. Japan Hematology Analyzers and Reagents Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product And Services
      • 8.3.3.2.2. By End User
      • 8.3.3.2.3. By Application
  • 8.3.4. South Korea Hematology Analyzers and Reagents Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product And Services
      • 8.3.4.2.2. By End User
      • 8.3.4.2.3. By Application
  • 8.3.5. Australia Hematology Analyzers and Reagents Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product And Services
      • 8.3.5.2.2. By End User
      • 8.3.5.2.3. By Application

9. Middle East & Africa Hematology Analyzers and Reagents Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product And Services
  • 9.2.2. By End User
  • 9.2.3. By Application
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Hematology Analyzers and Reagents Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product And Services
      • 9.3.1.2.2. By End User
      • 9.3.1.2.3. By Application
  • 9.3.2. UAE Hematology Analyzers and Reagents Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product And Services
      • 9.3.2.2.2. By End User
      • 9.3.2.2.3. By Application
  • 9.3.3. South Africa Hematology Analyzers and Reagents Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product And Services
      • 9.3.3.2.2. By End User
      • 9.3.3.2.3. By Application

10. South America Hematology Analyzers and Reagents Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product And Services
  • 10.2.2. By End User
  • 10.2.3. By Application
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Hematology Analyzers and Reagents Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product And Services
      • 10.3.1.2.2. By End User
      • 10.3.1.2.3. By Application
  • 10.3.2. Colombia Hematology Analyzers and Reagents Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product And Services
      • 10.3.2.2.2. By End User
      • 10.3.2.2.3. By Application
  • 10.3.3. Argentina Hematology Analyzers and Reagents Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product And Services
      • 10.3.3.2.2. By End User
      • 10.3.3.2.3. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Hematology Analyzers and Reagents Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Sysmex Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Danaher Corporation
• 15.3. Nihon Kohden Corporation
• 15.4. Siemens Healthineers AG
• 15.5. Abbott Laboratories
• 15.6. Boule Diagnostics AB
• 15.7. Bio-Rad Laboratories Inc.
• 15.8. Biosystems S.A.
• 15.9. EKF Diagnostics Holdings Plc
• 15.10. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer